Bayer, coveting top spots in animal and consumer health, may eye deals for Zoetis, Pfizer OTC

Bayer's position in the OTC and animal health markets has slipped thanks to some big-time consolidation moves from its rivals. But the German pharma may have a big-time move of its own up its sleeve, Reuters' sources say--and it could include animal health leader Zoetis ($ZTS) or Pfizer's ($PFE) consumer offerings. More from FiercePharma

Read more on